{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:04:50Z","timestamp":1781780690532,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/dmd.113.051565","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T03:56:53Z","timestamp":1366775813000},"page":"1389-1397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4"],"prefix":"10.1016","volume":"41","author":[{"given":"Yukiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Izukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Finel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.051565_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/clinchem\/22.6.777","article-title":"Gas-chromatographic analysis for therapeutic concentrations of amitriptyline and nortriptyline in plasma, with use of a nitrogen detector","volume":"22","author":"Bailey","year":"1976","journal-title":"Clin Chem"},{"key":"10.1124\/dmd.113.051565_bib2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/clinchem\/22.10.1697","article-title":"Gas-chromatographic analysis for therapeutic concentration of imipramine and disipramine in plasma, with use of a nitrogen detector","volume":"22","author":"Bailey","year":"1976","journal-title":"Clin Chem"},{"key":"10.1124\/dmd.113.051565_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1986.tb02946.x","article-title":"Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration","volume":"26","author":"Blyden","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.113.051565_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/dmd.109.030676","article-title":"Investigation into UDP-glucuronosyltransferase (UGT) enzyme kinetics of imidazole- and triazole-containing antifungal drugs in human liver microsomes and recombinant UGT enzymes","volume":"38","author":"Bourcier","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.2005.02446.x","article-title":"S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen","volume":"60","author":"Bowalgaha","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.113.051565_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.113.051565_bib7","first-page":"340","article-title":"Biphasic kinetics of quaternary ammonium glucuronide formation from amitriptyline and diphenhydramine in human liver microsomes","volume":"25","author":"Breyer-Pfaff","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0090-9556(24)15156-2","article-title":"Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes","volume":"28","author":"Breyer-Pfaff","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib9","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-07-2245","article-title":"Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.051565_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/dmd.107.019406","article-title":"Glucuronidation of tobacco-specific nitrosamines by UGT2B10","volume":"36","author":"Chen","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib11","first-page":"838","article-title":"Species differences in N-glucuronidation","volume":"26","author":"Chiu","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/FPC.0b013e328348c76b","article-title":"Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants","volume":"21","author":"Erickson-Ridout","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.051565_bib13","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1124\/dmd.107.016402","article-title":"Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib14","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)07355-6","article-title":"Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein","volume":"24","author":"Green","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib16","first-page":"860","article-title":"Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(24)15358-5","article-title":"In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model","volume":"28","author":"Houston","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib19","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/bbrc.1993.1847","article-title":"cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily","volume":"194","author":"Jin","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.113.051565_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/00498254.2011.563327","article-title":"N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases","volume":"41","author":"Kaivosaari","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.051565_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.108.021709","article-title":"Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes","volume":"36","author":"Kaivosaari","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1124\/mol.107.037093","article-title":"Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10","volume":"72","author":"Kaivosaari","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.051565_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/dmd.104.001925","article-title":"Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s)","volume":"33","author":"Kaji","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib25","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.bcp.2004.02.014","article-title":"Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4","volume":"67","author":"Kaku","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.051565_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1124\/dmd.107.019539","article-title":"Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans","volume":"36","author":"Klieber","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/dmd.110.035600","article-title":"Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes","volume":"39","author":"Koga","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FPC.0b013e328011b598","article-title":"Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6","volume":"17","author":"Kurkela","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.051565_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hup.403","article-title":"Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes","volume":"17","author":"Linnet","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/dmd.113.051565_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/dmd.30.6.636","article-title":"Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms","volume":"30","author":"Nakajima","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1124\/dmd.112.045625","article-title":"Preparation of a specific monoclonal antibody against human UDP-glucuronosyltransferase (UGT) 1A9 and evaluation of UGT1A9 protein levels in human tissues","volume":"40","author":"Oda","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/jpet.104.073114","article-title":"N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7","volume":"311","author":"Staines","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051565_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.051565_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human udp-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051565_bib35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1124\/dmd.109.030981","article-title":"Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.051565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:09:29Z","timestamp":1739905769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624097484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0090955624097484"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.051565","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.051565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}